Peer Review History

Original SubmissionAugust 26, 2020
Decision Letter - Khin Thet Wai, Editor

PONE-D-20-26785

Parents’ and guardians’ views and experiences of accessing routine childhood vaccinations during the coronavirus (COVID-19) pandemic: A mixed-methods study in England

PLOS ONE

Dear Dr. Bell,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Nov 17 2020 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.
  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.
  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols

We look forward to receiving your revised manuscript.

Kind regards,

Khin Thet Wai, MBBS, MPH, MA (Population & Family Planning Resear

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Please include additional information regarding the qualitative interview guide used in the study and ensure that you have provided sufficient details that others could replicate the analyses. For instance, if you developed a interview guide as part of this study and it is not under a copyright more restrictive than CC-BY, please include a copy, in both the original language and English, as Supporting Information.

3. In the Methods, please discuss whether and how the interview guide was pre-tested. If this did not occur, please provide the rationale for not doing so.

4. We note that you have stated that you will provide repository information for your data at acceptance. Should your manuscript be accepted for publication, we will hold it until you provide the relevant accession numbers or DOIs necessary to access your data. If you wish to make changes to your Data Availability statement, please describe these changes in your cover letter and we will update your Data Availability statement to reflect the information you provide.

5. Please include a separate caption for each figure in your manuscript.

6. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: No

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: This is a comprehensive and interesting study about exploring the experiences of routine childhood vaccination in the midst of COVID-19 pandemic. This is an important area of study given the extensive data form diverse settings.

The manuscript is written comprehensively and research design is appropriate with proper integration of quantitative and qualitative findings. Exploring also the aspects of healthcare providers for vaccination during pandemic will provide complete picture of lessons and programmatic implications in improving vaccination services during pandemic situation. Overall, the study provide valuable insights for barriers in uptake immunization services during pandemic situation with high applicability for local and global context. The comments were shown below.

Introduction

•The problem is properly introduced and the justification is robust enough to support the objective of the study.

Methods

•Line 97: Why the study included only 18 months or under children although GP surgery provided immunization up to more than 3 years old?

•Line 143: What about the association between awareness of routine vaccination with the gender and education status of parents or guardians?

•In recruiting and collecting data for semi-structured interview, there is no information about characteristics of interviewers and saturation of data.

•Line 165: Is it online based written consent?

•Line 169 & 174: What are meanings of abbreviations; SB, PP, RC and SM-J?

•Line 185 & 198: Please check appropriate reference for “Error! Reference Source not found”

•Line 194 – 197: The selection criteria for choosing 61 parents among 530 with detail contact information is not clear. Only 19 out of 61 invited (31%) were interviewed which might lead to non-response bias.

•In table 2: There are only 2 respondents whose children were overdue a vaccination. It is questionable whether the data is saturated enough in exploring the barriers of taking vaccination among such group.

Finding

•Table 5: Why medium income level and age group 6-8 months were taken as reference in logistic model?

•Line 237 – 247: The order of factors interpreted in text is better to follow the order as shown in table .

•Line 248 – 264: It would be better to include sub-heading for these paragraphs as these paragraphs provide information not directly linked with factors associated with lack of awareness.

•Line 268: Please check appropriate reference for “Error! Reference Source not found”

•Line 369: Who or which organization sent confusing text-messages?

Discussion and conclusion

•Although the scope of the study is big, the discussion provides solid messages to support the conclusion. In presenting discussion, it would be better to follow the sequence of information; capability, motivation and opportunity as written in results part for better linkage.

Reviewer #2: This is well-organized/planned survey for the effects of pandemic on routine immunization for infants below 18 months. This is very important point for ongoing COVID-19 pandemic (potential further wave) or other pandemics in future.

Authors clearly defined their aims and methods using prompt references.

There are some minor points (maybe limitations)

- Number of interviewed participants is low; only 19. Regarding enrollment number, it is difficult to evaluate this small group response.

- Your title includes terms "parents", however as usual for studies during infancy, 90%of responses came from mothers. This is not parent's view, this is mother's perspective.

- Table 4-5 (colored-component of COMb) is busy to follow-up, maybe move to supplementary file or need to re-organize.

- I am not sure the Journal Policy (page limitations), your Results section is too long and difficult to-follow up.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: Yes: Ener Cagri Dinleyici

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Revision 1

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

________________________________________

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

________________________________________

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: No

We have added the following to the manuscript (lines 501-504).

‘Data Availability Statement: The full dataset will be made available to bona fide researchers upon request and agreement by the study team. Further information on the data and access conditions can be found through the LSHTM Data Compass at: https://doi.org/10.17037/DATA.00001861.’

Reviewer #2: Yes

________________________________________

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

________________________________________

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: This is a comprehensive and interesting study about exploring the experiences of routine childhood vaccination in the midst of COVID-19 pandemic. This is an important area of study given the extensive data form diverse settings.

The manuscript is written comprehensively and research design is appropriate with proper integration of quantitative and qualitative findings. Exploring also the aspects of healthcare providers for vaccination during pandemic will provide complete picture of lessons and programmatic implications in improving vaccination services during pandemic situation. Overall, the study provides valuable insights for barriers in uptake immunization services during pandemic situation with high applicability for local and global context. The comments were shown below.

Thank you so much to reviewer 1 for taking the time to read and review our manuscript.

Introduction

•The problem is properly introduced and the justification is robust enough to support the objective of the study.

Methods

•Line 97: Why the study included only 18 months or under children although GP surgery provided immunization up to more than 3 years old?

• During the COVID-19 pandemic, the priority for vaccination services is to maintain delivery of vaccinations for babies, infants and pre-school children.

• The recruitment for our study specifically focused on parents and guardians with children aged 18 months or under as most childhood vaccinations delivered in general practice are due before a child reaches 18 months of age (i.e. vaccinations are scheduled at 8 weeks, 12, weeks, 16 weeks and 12 months). There is then a gap in when routine childhood vaccinations are due until a child reaches 3 years and 4 months.

• As we wanted to find out about parents and guardians views and experiences of accessing routine childhood vaccinations we chose to focus on this time period (18 months or under) as one in which children would most likely be due a vaccination.

• The inclusion criteria were discussed with immunisation representatives at Public Health England.

We have added the following to the manuscript, in lines 97-104:

‘Our study specifically focused on parents and guardians with children aged 18 months or under as most childhood vaccinations delivered in general practice in the UK are due before a child reaches 18 months of age (i.e. vaccinations are scheduled at 8 weeks, 12 weeks, 16 weeks and 12 months). There is then a gap in when routine childhood vaccinations are due until a child reaches the age of 3 years and 4 months. Including children up to 18 months meant we could capture the views and experiences of parents and guardians whose children may have been overdue their 12 month vaccinations.’

•Line 143: What about the association between awareness of routine vaccination with the gender and education status of parents or guardians?

Thank you. These would have been interesting to examine. In designing the study, we chose to ask about location, ethnicity, employment status, household income, and number of children. An exploration of gender as an influencing factor in the study was not possible due to the limited number of men completing the survey, and we did not collect data on additional demographic factors that may have been of interest, such as education level, health literacy and religious beliefs.

A note referring to this is now included in the discussion section (lines 487-490)

•In recruiting and collecting data for semi-structured interview, there is no information about characteristics of interviewers and saturation of data.

Lines 178-180: ‘Interviews were conducted between 27th April and 27th May 2020 by SB and PP, qualitative researchers who have extensive experience in conducting interviews on the topic of vaccination with parents.’

Through the analysis of free-text responses and interviews the authors feel that we achieved data saturation, as no new themes were emerging from open-text or interview responses.

•Line 165: Is it online based written consent?

We have added the following to lines 173-174: ‘Written informed consent was obtained from each participant. Depending on the preference of the participant, the consent form was sent and returned via email or post.’

•Line 169 & 174: What are meanings of abbreviations; SB, PP, RC and SM-J?

These are the initials of the study researchers.

•Line 185 & 198: Please check appropriate reference for “Error! Reference Source not found”

Thank you. We have addressed these error messages – which seem to have occurred as the paper was converted from word document to a PDF when uploaded to the journal.

•Line 194 – 197: The selection criteria for choosing 61 parents among 530 with detail contact information is not clear. Only 19 out of 61 invited (31%) were interviewed which might lead to non-response bias.

Our recruitment approach is outlined in lines 166-172:

‘Respondents who had left their details were purposively contacted based on a range of characteristics, including ethnicity, household income, and geographical location. We also purposefully aimed to interview survey participants who did not provide free-text responses and respondents whose children were overdue a vaccination, or due a vaccination within 4 weeks of taking part in the survey.’

And we have added the following to the limitations section, lines 476-479:

‘A limitation of the interviews was that only 19 of 61 invited respondents took part, which may have been partly due to respondents not seeing the invitation email or not having the time to participate. It may be that those that took part in interviews had a stronger interest in vaccinations and a different view to those that did not take part.’

•In table 2: There are only 2 respondents whose children were overdue a vaccination. It is questionable whether the data is saturated enough in exploring the barriers of taking vaccination among such group.

Interviews were conducted as part of the study to add to the data collected through the survey. As part of the survey, rich and detailed information was obtained in open-text responses and findings from the interviews supplemented this. Through the analysis of open-text responses and interviews the authors feel that we achieved data saturation, as no new themes were emerging from open-text or interview responses.

We have added this to the strengths section of the paper (lines 471-475):

‘Using a mixed-methods approach in this study allowed for a more complete insight into parents’ and guardians’ views and experiences of vaccinating young children during the COVID-19 pandemic in England than could have been achieved using one method only. As part of the survey, rich and detailed information was obtained in free-text responses and findings from the interviews supplemented this.’

Finding

•Table 5: Why medium income level and age group 6-8 months were taken as reference in logistic model?

For the income groups the data was split into quartiles and the lower and upper qualities were compared to the middle group so as to capture differences across income. Similarly, the middle age group was taken so as to better compare between those with a high number of vaccines typically scheduled (early infancy and around 12 months) and a group where vaccines are less often scheduled.

•Line 237 – 247: The order of factors interpreted in text is better to follow the order as shown in table.

Thank you. We have changed the order of the factors interpreted in the text to reflect the order of the table.

•Line 248 – 264: It would be better to include sub-heading for these paragraphs as these paragraphs provide information not directly linked with factors associated with lack of awareness.

Thank you. This paragraph describes in more detail factors associated with lack of awareness of vaccination service continuation. We have clarified this in the text.

•Line 268: Please check appropriate reference for “Error! Reference Source not found”

Thank you. We have addressed these error messages – which seem to have occurred as the paper was converted from word document to a PDF when uploaded to the journal.

•Line 369: Who or which organization sent confusing text-messages?

Thank you. We have now clarified this to say (lines 386-387)

‘Several interview participants also discussed receiving confusing text-messages about their appointment from their GP practice that stated their appointments had been cancelled and they should not attend the GP practice’.

Discussion and conclusion

•Although the scope of the study is big, the discussion provides solid messages to support the conclusion. In presenting discussion, it would be better to follow the sequence of information; capability, motivation and opportunity as written in results part for better linkage.

Thank you. We have further reflected on the order of the discussion, and have kept the current flow of information as we think that it best highlights the key issues and keeps the word count down.

Reviewer #2: This is well-organized/planned survey for the effects of pandemic on routine immunization for infants below 18 months. This is very important point for ongoing COVID-19 pandemic (potential further wave) or other pandemics in future.

Thank you so much to reviewer 2. We appreciate you taking the time to read and review our manuscript.

Authors clearly defined their aims and methods using prompt references.

There are some minor points (maybe limitations)

- Number of interviewed participants is low; only 19. Regarding enrolment number, it is difficult to evaluate this small group response.

The interviews were conducted to supplement the survey findings, which included detailed and lengthy open-text responses, and provided a more comprehensive understanding of parents’ views and experiences. We purposively invited participants with less detailed open text responses for interview. The authors feel that due to the rich information obtained in open-text survey responses and the interviews we achieved a stage where no new themes were emerging from the data.

- Your title includes terms "parents", however as usual for studies during infancy, 90%of responses came from mothers. This is not parent's view, this is mother's perspective.

Thank you for your comment. On reflection, we agree that it is a limitation that more male participants did not take part in the study; however, the study was not just open to female participants (and some male participants did take part). We therefore want to keep the proposed title and have added to the limitations section that few male parents and guardians participated.

- Table 4-5 (coloured-component of COM-B) is busy to follow-up, maybe move to supplementary file or need to re-organize.

We have further reflected on the layout and location of the tables, and have kept the tables within the main text as we think they are best placed here. We have condensed the quotations in table 4 to reduce the size of the table and make the table easier to read.

- I am not sure the Journal Policy (page limitations), your Results section is too long and difficult to-follow up.

Thank you. We have shortened and changed the order of the Results section to be clearer. The length of the manuscripts fits within the journal requirements.

Attachments
Attachment
Submitted filename: PLOS ONE_response to reviewers_18.11.20.docx
Decision Letter - Khin Thet Wai, Editor

Parents’ and guardians’ views and experiences of accessing routine childhood vaccinations during the coronavirus (COVID-19) pandemic: A mixed methods study in England

PONE-D-20-26785R1

Dear Dr. Bell,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Khin Thet Wai, MBBS, MPH, MA (Population & Family Planning Resear

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #2: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #2: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #2: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #2: (No Response)

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #2: No

Formally Accepted
Acceptance Letter - Khin Thet Wai, Editor

PONE-D-20-26785R1

Parents’ and guardians’ views and experiences of accessing routine childhood vaccinations during the coronavirus (COVID-19) pandemic: A mixed methods study in England

Dear Dr. Bell:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Khin Thet Wai

Academic Editor

PLOS ONE

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .